112 I. Nazarenko et al. 133. Meletis K, Wirta V, Hede SM, Nistér M, Lundeberg J, Frisén J. p53 suppresses the self-renewal of adult neural stem cells. Development. 2006;133:363–9. 134. Bonavia R, Inda MM, Cavenee WK, Furnari FB. Hetero- geneity maintenance in glioblastoma: a social network. Can- cer Res. 2011;71:4055–60. 135. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, et al. CD133(+) and CD133(-) glioblastoma-- derived cancer stem cells show differential growth character- istics and molecular proﬁles. Cancer Res. 2007;67:4010–15. 136. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell. 2010;17:362–75. 137. Clarke DL, Johansson CB, Wilbertz J, Veress B, Nilsson E, Karlström H, et al. Generalized potential of adult neural stem cells. Science. 2000;288:1660–3. 138. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumori- genic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004;64:7011–21. 139. Mazzoleni S, Politi LS, Pala M, Cominelli M, Franzin A, Sergi Sergi L, et al. Epidermal growth factor receptor expression identiﬁes functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res. 2010;70: 7500–13. 140. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identiﬁcation of human brain tumour initiating cells. Nature. 2004;432:396–401. 141. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radio- resistance by preferential activation of the DNA damage response. Nature. 2006;444:756–60. 142. Lindberg N, Kastemar M, Olofsson T, Smits A, Uhrbom L. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene. 2009;28:2266–75. 143. Seidel S, Garvalov BK, Wirta V, von Stechow L, Schänzer A, Meletis K, et al. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain. 2010; 133:983–95. 144. Oka N, Soeda A, Inagaki A, Onodera M, Maruyama H, Hara A, et al. VEGF promotes tumorigenesis and angiogen- esis of human glioblastoma stem cells. Biochem Biophys Res Commun. 2007;360:553–9. 145. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007;11:69–82. 146. Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 2008;68: 6043–8. 147. Xie Z. Brain tumor stem cells. Neurochem Res. 2009;34: 2055–66. 148. Deinhardt F. The biology of primate retroviruses. In: Klein G. editor. Viral Oncology. New York: Raven press; 1980. p 359–98. 149. Nistér M, Westermark B. Mechanisms of altered growth control; Growth factors. In Bigner DD, McLendon RE, Bruner JM, editors. Pathology of tumors of the nervous system. 6th ed. Vol 1. London: Arnold, Hodder Headline Group; 1998. p 83–116. 150. Uhrbom L, Hesselager G, Nister M, Westermark B. Induc- tion of brain tumors in mice using a recombinant platelet- derived growth factor B-chain retrovirus. Cancer Res. 1998; 58:5275–9. 151. Uhrbom L, Hesselager G, Ostman A, Nister M, Westermark B. Dependence of autocrine growth factor stim- ulation in platelet-derived growth factor-B-induced mouse brain tumor cells. Int J Cancer. 2000;85:398–406. 152. Fisher GH, Orsulic S, Holland E, Hively WP, Li Y, Lewis BC, et al. Development of a ﬂexible and speciﬁc gene delivery system for production of murine tumor models. Oncogene. 1999;18:5253–60. 153. Uhrbom L, Holland EC. Modeling gliomagenesis with somatic cell gene transfer using retroviral vectors. J Neurooncol. 2001;53:297–305. 154. Hesselager G, Uhrbom L, Westermark B, Nistér M. Com- plementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res. 2003;63:4305–9. 155. See WL, Miller JP, Squatrito M, Holland E, Resh MD, Koff A. Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deﬁcient mice with growth factor-induced oligodendro- gliomas. Oncogene. 2010;29:1720–31. 156. Tchougounova E, Kastemar M, Brasater D, Holland EC, Westermark B, Uhrbom L. Loss of Arf causes tumor pro- gression of PDGFB-induced oligodendroglioma. Oncogene. 2007;26:6289–96. 157. Westermark UK, Lindberg N, Roswall P, Bråsäter D, Helgadottir HR, Hede SM, et al. RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability. Neuro Oncol. 2011;13:1277–87. 158. Assanah M, Lochhead R, Ogden A, Bruce J, Goldman J, Canoll P. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor- expressing retroviruses. J Neurosci. 2006;26:6781–90. 159. Assanah MC, Bruce JN, Suzuki SO, Chen A, Goldman JE, Canoll P. PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain. Glia. 2009;57: 1835–47. 160. Appolloni I, Calzolari F, Tutucci E, Caviglia S, Terrile M, Corte G, et al. PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors. Int J Cancer. 2009;124:2251–9. 161. Calzolari F, Appollini I, Tutucci E, Caviglia S, Terrile M, Corte G, et al. Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis. Neoplasia. 2008;10:1373–82. 162. Hede SM, Hansson I, Aﬁnk GB, Eriksson A, Nazarenko I, Andrae J, et al. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 background. Glia. 2009;57:1143–53. 163. Nazarenko I, Hedrén A, Sjödin H, Orrego A, Andrae J, Aﬁnk GB, et al. Brain abnormalities and glioma-like lesions in mice overexpressing the long isoform of PDGF-A in astrocytic cells. PLoS One. 2011;6:e18303. 164. Raff M. Glial cell diversiﬁcation in the rat optic nerve. Science. 1989;243:1450–5. 165. Raff MC, Miller RH, Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendro- cyte depending on the culture medium. Nature. 1983;303: 390–6. 166. Gil-Perotin S, Marin-Husstege M, Li J, Soriano-Navarro M, Zindy F, Roussel MF, et al. Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. J Neurosci. 2006;26:1107–16.